Cargando…

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer

In estrogen receptor positive (ER+) breast cancer therapy, estrogen receptors (ERs) are the major targeting molecules. ER-targeted therapy has provided clinical benefits for approximately 70% of all breast cancer patients through targeting the ERα subtype. In recent years, mechanisms underlying brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Song, Lin, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Screening, Diagnosis, and Treatment of Breast Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036337/ https://www.ncbi.nlm.nih.gov/pubmed/35450488 http://dx.doi.org/10.1177/15330338221090351

Ejemplares similares

Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis
por: Zhang, Duo, et al.
Publicado: (2022)

Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population
por: Zhang, Yusi, et al.
Publicado: (2022)

A Realistic Breast Phantom Proposal for 3D Image Reconstruction in Digital Breast Tomosynthesis
por: Polat, Adem, et al.
Publicado: (2022)

The use of Hybrid Techniques in Whole-Breast Radiotherapy: A Systematic Review
por: Karaca, Sibel
Publicado: (2022)

Review on Deep Learning-Based CAD Systems for Breast Cancer Diagnosis
por: Arun Kumar, S., et al.
Publicado: (2023)

The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer
por: Chen, Keyu, et al.
Publicado: (2022)

Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
por: Zhang, Hongyi, et al.
Publicado: (2022)

Impact of Sentinel Lymph Node Biopsy on Treatment Decision and Survival in Patients Aged ≥70 Years with Breast Cancer: A Retrospective Study
por: Gu, Chongshan, et al.
Publicado: (2022)

Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study
por: Thanestada, Jirawat, et al.
Publicado: (2022)

Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor‐Positive Metastatic Breast Cancer
por: Jin, Liang, et al.
Publicado: (2020)

Tracing 2D Growth of Pancreatic Tumoroids Using the Combination of Image Processing Techniques and Mini-Opto Tomography Imaging System
por: Akbaba, Cihat Ediz, et al.
Publicado: (2023)

Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer
por: Grinshpun, Albert
Publicado: (2023)

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
por: Yu, Limeng, et al.
Publicado: (2023)

Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor‐Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care‐BC): A Randomized Controlled Phase III Trial
por: Niikura, Naoki, et al.
Publicado: (2019)

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023)

Safety and Efficacy of Carbon Nanoparticle-Labeled Lymph Node Dissection in Radical Resection of Gastric Cancer: A Systematic Review and Meta-Analysis
por: Zhu, Chenglou, et al.
Publicado: (2023)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Systemic and Local Effects Among Patients With Betel Quid-Related Oral Cancer
por: Chuang, Hui-Ching, et al.
Publicado: (2022)

Estrogen receptor and progesterone receptor status of breast cancer patients of eastern India: A multi-institutional study
por: Chatterjee, Koushik, et al.
Publicado: (2018)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling
por: Wang, Shuo, et al.
Publicado: (2022)

Quantitative Measurement of Perineural Invasion for Prognosis Analysis of Oral Cavity Cancer Treated by Radical Surgery With or Without Adjuvant Therapy
por: Fan, Kang-Hsing, et al.
Publicado: (2023)

Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy
por: Kaufman, Peter A., et al.
Publicado: (2019)

Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case‐Control Study in Northern and Eastern China and Implications for Chemoprevention
por: Wang, Fei, et al.
Publicado: (2017)

Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC
por: Wang, Hao, et al.
Publicado: (2022)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
por: Dong, Peng, et al.
Publicado: (2022)

Predictors of Readmission After Pulmonary Resection in Patients With Lung Cancer: A Systematic Review and Meta-analysis
por: Liu, Jie, et al.
Publicado: (2022)

The Effectiveness of Population Mass Screening to Oral Cancer: A Simulation Study
por: Su, Chiu-Wen, et al.
Publicado: (2022)

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China
por: Li, Tao, et al.
Publicado: (2023)

Bronchial Artery Chemoembolization With Radiopaque Doxorubicin Eluding Beads in Patients With Malignant Hemoptysis from Metastatic Lung Cancer
por: Nezami, Nariman, et al.
Publicado: (2022)

The Applications and Potential Developments of Ultrasound in Oral Cancer Management
por: Lo, Wu-Chia, et al.
Publicado: (2022)

Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review
por: Fontes-Lemus, José I., et al.
Publicado: (2023)

The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer
por: Zhang, Zaibo, et al.
Publicado: (2023)

Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study
por: Mei, Zhou-Fang, et al.
Publicado: (2023)

Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer
por: Mansur, Arian, et al.
Publicado: (2023)

Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis
por: Pang, Xue-Li, et al.
Publicado: (2023)

Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up
por: Finn, Richard S., et al.
Publicado: (2021)

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer
por: Xia, Youli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2e5bm4t0fdr0qd4rgbq4gc63a2